FHIR Cross-Version Extensions package for FHIR R4 from FHIR R5 - Version 0.0.1-snapshot-2. See the Directory of published versions
| Official URL: http://hl7.org/fhir/5.0/ValueSet/R5-v2-0227-for-R4 | Version: 0.0.1-snapshot-2 | |||
| Standards status: Informative | Maturity Level: 0 | Computable Name: R5_v2_0227_for_R4 | ||
| This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v2-0227 | 2.0.0 for use in FHIR R4. Concepts not present here have direct equivalent mappings crossing all versions from R5 to R4. | 
    
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v2-0227 version 2.ext.0| Code | Display | 
| AB | Abbott Laboratories | 
| AD | Adams Laboratories, Inc. | 
| ALP | Alpha Therapeutic Corporation | 
| AR | Armour | 
| AVB | Aventis Behring L.L.C. | 
| AVI | Aviron | 
| BA | Baxter Healthcare Corporation | 
| BAH | Baxter Healthcare Corporation | 
| BAY | Bayer Corporation | 
| BP | Berna Products | 
| BPC | Berna Products Corporation | 
| MIP | Bioport Corporation | 
| CNJ | Cangene Corporation | 
| CMP | Celltech Medeva Pharmaceuticals | 
| CEN | Centeon L.L.C. | 
| CHI | Chiron Corporation | 
| CON | Connaught | 
| DVC | DynPort Vaccine Company, LLC | 
| EVN | Evans Medical Limited | 
| GEO | GeoVax Labs, Inc. | 
| SKB | GlaxoSmithKline | 
| GRE | Greer Laboratories, Inc. | 
| IAG | Immuno International AG | 
| IUS | Immuno-U.S., Inc. | 
| KGC | Korea Green Cross Corporation | 
| LED | Lederle | 
| MBL | Massachusetts Biologic Laboratories | 
| MA | Massachusetts Public Health Biologic Laboratories | 
| MED | MedImmune, Inc. | 
| MSD | Merck & Co., Inc. | 
| IM | Merieux | 
| MIL | Miles | 
| NAB | NABI | 
| NYB | New York Blood Center | 
| NAV | North American Vaccine, Inc. | 
| NOV | Novartis Pharmaceutical Corporation | 
| NVX | Novavax, Inc. | 
| OTC | Organon Teknika Corporation | 
| ORT | Ortho-Clinical Diagnostics | 
| PD | Parkedale Pharmaceuticals | 
| PWJ | PowderJect Pharmaceuticals | 
| PRX | Praxis Biologics | 
| PMC | sanofi pasteur | 
| JPN | The Research Foundation for Microbial Diseases of Osaka University | 
| SCL | Sclavo, Inc. | 
| SOL | Solvay Pharmaceuticals | 
| SI | Swiss Serum and Vaccine Inst. | 
| TAL | Talecris Biotherapeutics | 
| USA | United States Army Medical Research and Material Command | 
| VXG | VaxGen | 
| WA | Wyeth-Ayerst | 
| WAL | Wyeth-Ayerst | 
| ZLB | ZLB Behring | 
| OTH | Other manufacturer | 
| UNK | Unknown manufacturer | 
This value set expansion contains 55 concepts.
| Code | System | Display | 
| AB | http://terminology.hl7.org/CodeSystem/v2-0227 | Abbott Laboratories | 
| AD | http://terminology.hl7.org/CodeSystem/v2-0227 | Adams Laboratories, Inc. | 
| ALP | http://terminology.hl7.org/CodeSystem/v2-0227 | Alpha Therapeutic Corporation | 
| AR | http://terminology.hl7.org/CodeSystem/v2-0227 | Armour | 
| AVB | http://terminology.hl7.org/CodeSystem/v2-0227 | Aventis Behring L.L.C. | 
| AVI | http://terminology.hl7.org/CodeSystem/v2-0227 | Aviron | 
| BA | http://terminology.hl7.org/CodeSystem/v2-0227 | Baxter Healthcare Corporation | 
| BAH | http://terminology.hl7.org/CodeSystem/v2-0227 | Baxter Healthcare Corporation | 
| BAY | http://terminology.hl7.org/CodeSystem/v2-0227 | Bayer Corporation | 
| BP | http://terminology.hl7.org/CodeSystem/v2-0227 | Berna Products | 
| BPC | http://terminology.hl7.org/CodeSystem/v2-0227 | Berna Products Corporation | 
| MIP | http://terminology.hl7.org/CodeSystem/v2-0227 | Bioport Corporation | 
| CNJ | http://terminology.hl7.org/CodeSystem/v2-0227 | Cangene Corporation | 
| CMP | http://terminology.hl7.org/CodeSystem/v2-0227 | Celltech Medeva Pharmaceuticals | 
| CEN | http://terminology.hl7.org/CodeSystem/v2-0227 | Centeon L.L.C. | 
| CHI | http://terminology.hl7.org/CodeSystem/v2-0227 | Chiron Corporation | 
| CON | http://terminology.hl7.org/CodeSystem/v2-0227 | Connaught | 
| DVC | http://terminology.hl7.org/CodeSystem/v2-0227 | DynPort Vaccine Company, LLC | 
| EVN | http://terminology.hl7.org/CodeSystem/v2-0227 | Evans Medical Limited | 
| GEO | http://terminology.hl7.org/CodeSystem/v2-0227 | GeoVax Labs, Inc. | 
| SKB | http://terminology.hl7.org/CodeSystem/v2-0227 | GlaxoSmithKline | 
| GRE | http://terminology.hl7.org/CodeSystem/v2-0227 | Greer Laboratories, Inc. | 
| IAG | http://terminology.hl7.org/CodeSystem/v2-0227 | Immuno International AG | 
| IUS | http://terminology.hl7.org/CodeSystem/v2-0227 | Immuno-U.S., Inc. | 
| KGC | http://terminology.hl7.org/CodeSystem/v2-0227 | Korea Green Cross Corporation | 
| LED | http://terminology.hl7.org/CodeSystem/v2-0227 | Lederle | 
| MBL | http://terminology.hl7.org/CodeSystem/v2-0227 | Massachusetts Biologic Laboratories | 
| MA | http://terminology.hl7.org/CodeSystem/v2-0227 | Massachusetts Public Health Biologic Laboratories | 
| MED | http://terminology.hl7.org/CodeSystem/v2-0227 | MedImmune, Inc. | 
| MSD | http://terminology.hl7.org/CodeSystem/v2-0227 | Merck & Co., Inc. | 
| IM | http://terminology.hl7.org/CodeSystem/v2-0227 | Merieux | 
| MIL | http://terminology.hl7.org/CodeSystem/v2-0227 | Miles | 
| NAB | http://terminology.hl7.org/CodeSystem/v2-0227 | NABI | 
| NYB | http://terminology.hl7.org/CodeSystem/v2-0227 | New York Blood Center | 
| NAV | http://terminology.hl7.org/CodeSystem/v2-0227 | North American Vaccine, Inc. | 
| NOV | http://terminology.hl7.org/CodeSystem/v2-0227 | Novartis Pharmaceutical Corporation | 
| NVX | http://terminology.hl7.org/CodeSystem/v2-0227 | Novavax, Inc. | 
| OTC | http://terminology.hl7.org/CodeSystem/v2-0227 | Organon Teknika Corporation | 
| ORT | http://terminology.hl7.org/CodeSystem/v2-0227 | Ortho-Clinical Diagnostics | 
| PD | http://terminology.hl7.org/CodeSystem/v2-0227 | Parkedale Pharmaceuticals | 
| PWJ | http://terminology.hl7.org/CodeSystem/v2-0227 | PowderJect Pharmaceuticals | 
| PRX | http://terminology.hl7.org/CodeSystem/v2-0227 | Praxis Biologics | 
| PMC | http://terminology.hl7.org/CodeSystem/v2-0227 | sanofi pasteur | 
| JPN | http://terminology.hl7.org/CodeSystem/v2-0227 | The Research Foundation for Microbial Diseases of Osaka University | 
| SCL | http://terminology.hl7.org/CodeSystem/v2-0227 | Sclavo, Inc. | 
| SOL | http://terminology.hl7.org/CodeSystem/v2-0227 | Solvay Pharmaceuticals | 
| SI | http://terminology.hl7.org/CodeSystem/v2-0227 | Swiss Serum and Vaccine Inst. | 
| TAL | http://terminology.hl7.org/CodeSystem/v2-0227 | Talecris Biotherapeutics | 
| USA | http://terminology.hl7.org/CodeSystem/v2-0227 | United States Army Medical Research and Material Command | 
| VXG | http://terminology.hl7.org/CodeSystem/v2-0227 | VaxGen | 
| WA | http://terminology.hl7.org/CodeSystem/v2-0227 | Wyeth-Ayerst | 
| WAL | http://terminology.hl7.org/CodeSystem/v2-0227 | Wyeth-Ayerst | 
| ZLB | http://terminology.hl7.org/CodeSystem/v2-0227 | ZLB Behring | 
| OTH | http://terminology.hl7.org/CodeSystem/v2-0227 | Other manufacturer | 
| UNK | http://terminology.hl7.org/CodeSystem/v2-0227 | Unknown manufacturer | 
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies | 
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) | 
| Code | The code (used as the code in the resource instance) | 
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application | 
| Definition | An explanation of the meaning of the concept | 
| Comments | Additional notes about how to use the code |